Understanding long-term lung effects after COVID-19
Part of Infections, Lungs & breathing clinical trials.
This study looks at why some people develop long-term lung problems after COVID-19. It compares people who had severe COVID-19 and were hospitalized to those who had mild infections and recovered at home.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be at least 18 years old.
- You must have tested positive for COVID-19.
- You must not have had a lung disease before COVID-19 (like interstitial lung disease or other chronic lung conditions).
- You cannot currently smoke, vape, or use any inhaled products.
- You cannot be taking strong immune-suppressing medications (like methotrexate, CellCept, azathioprine, rituximab, cyclophosphamide, or other similar drugs).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at how COVID-19 may affect the lungs, heart, and kidneys in the months or years after the infection. It compares three groups: people who never had COVID, people who had COVID but recovered without organ problems, and people who had organ problems during COVID. The goal is to understand what long-term complications might arise.
This study looks at how COVID-19 can affect health and quality of life over the long term. It may help researchers understand symptoms that can last and what changes people experience after recovery.
This trial studies how your immune system responds in people with Long COVID after a past COVID-19 infection. It may help researchers understand why symptoms linger and how the body’s response could be targeted.
This trial studies people with mild to moderate COVID-19 symptoms to better understand and help “post-COVID” condition (ongoing effects after infection). You may be eligible if you’re an adult with a recent confirmed COVID-19 test and you agreed to take part.
This study looks at what health problems remain after a person was hospitalized for COVID-19. It may help doctors understand these long-lasting effects and how to care for people afterward.
This study looks at how long COVID affects the body and whether cardiopulmonary rehabilitation improves quality of life and physical function. It may help participants better understand their symptoms and see if a structured rehab program improves daily abilities.
Hear when a new COVID-19 trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.